## **Core Concept**
The use of misoprostol in the management of postpartum hemorrhage (PPH) is a critical pharmacological intervention. Misoprostol, a synthetic prostaglandin E1 analogue, is employed to induce uterine contractions and reduce bleeding. The World Health Organization (WHO) provides guidelines for its use, including the recommended dosage.

## **Why the Correct Answer is Right**
The WHO recommended dose of misoprostol for the treatment of postpartum hemorrhage is 600 micrograms sublingually or orally. This dose has been established based on evidence demonstrating its efficacy in reducing the risk of severe bleeding and related complications. Misoprostol works by stimulating uterine contractions, thereby helping to control hemorrhage. The 600 micrograms dose is considered effective and relatively safe for this indication.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Lower doses (e.g., 100 or 200 micrograms) may not be as effective in controlling severe postpartum hemorrhage.
- **Option B:** While 400 micrograms might be considered in some contexts, it is not the recommended dose by WHO for PPH management.
- **Option D:** Higher doses (e.g., 800 or 1000 micrograms) may increase the risk of side effects without providing additional benefit in controlling hemorrhage.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that misoprostol is particularly useful in settings where more commonly used treatments for PPH, such as oxytocin, are not available or have failed. However, its use is associated with side effects like nausea, vomiting, and diarrhea, which should be managed supportively.

## **Correct Answer:** C. 600 microgram.